- Fund Type: Open-End Fund
- Objective: Flexible Portfolio
- Asset Class: Asset Allocation
- Geographic Focus: Global
Adenium Sicav - Income Opportunity Fund
+ Add to WatchlistAFOQ20A:LX
88.65 EUR 0.03 0.03%As of 01:59:30 ET on 05/17/2013.
Snapshot for Adenium Sicav - Income Opportunity Fund (AFOQ20A)
| Year To Date: | -3.88% | 3-Month: | -4.86% | 3-Year: | -4.63% | 52-Week Range: | 88.62 - 95.79 |
|---|---|---|---|---|---|---|---|
| 1-Month: | -0.58% | 1-Year: | -8.40% | 5-Year: | - | Beta vs LUXXX: | 0.37 |
Fund Profile & Information for AFOQ20A
Adenium Sicav - Income Opportunity Fund is an open-end fund incorporated in Luxembourg. The Fund's objective is to achieve a short/medium term capital growth. The Fund uses flexible management of its assets, with a medium/low risk level and an investment horizon of 2 to 3 years. The Fund invests in other target UCITS and UCIs which primarily invest in equities, bonds and liquidity.
| Inception Date: | 03-03-2009 | Telephone: | - |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | - | ||
Fundamentals for AFOQ20A
| NAV | (on 2013-05-17) 88.65 |
|---|---|
| Assets (M) | (on 2013-05-17) 0.39 |
| Fund Leveraged | N |
| Minimum Investment | 1.00 |
| Minimum Subsequent Investment | 1.00 |
Dividends for AFOQ20A
No dividends reported
Fees & Expenses for AFOQ20A
| Front Load | - |
|---|---|
| Back Load | - |
| Current Mgmt Fee | 2.30 |
| Redemption Fee | - |
| 12b1 Fee | - |
| Expense Ratio | - |
Top Fund Holdings for AFOQ20A
Filing Date: 12/31/2012| Name | Position | Value | % of Total |
|---|---|---|---|
| BTPS 4 ¼ 07/01/14 | 155 | 160,503 | 24.899% |
| BTPS 2 06/01/13 | 136 | 136,551 | 21.183% |
| Absolute Insight Emerging Mark | 70,800 | 102,029 | 15.828% |
| PIMCO Global Bond Fund | 4,327 | 100,820 | 15.640% |
| Threadneedle Focus Investment | 83,479 | 100,150 | 15.536% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page